Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Schulz

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
American Journal of Clinical Pathology|November 13, 2004
Expression of matrix metalloproteinase (MMP)-1, MMP-2, MMP-9, cathepsin B, and urokinase plasminogen activator in non-skull base chordomaTakahiko Naka, Carsten Boltze, Doerthe Kuester, et al.
Blood|October 24, 2002
Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cellsJulio Aliberti, Oliver Schulz, Daniel J Pennington, et al.
Human Pathology|October 24, 2007
Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordomaTakahiko Naka, Doerthe Kuester, Carsten Boltze, et al.
Anticancer Research|September 10, 2014
TKI258, a multi-tyrosine kinase inhibitor is efficacious against human infant/childhood lymphoblastic leukemia in vitroJan Eucker, Chuanbing Zang, Yongan Zhou, et al.
Science (New York, N.Y.)|October 14, 2006
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphatesAndreas Pichlmair, Oliver Schulz, Choon Ping Tan, et al.
Nature Communications|January 18, 2023
Impact of the Euro 2020 championship on the spread of COVID-19Jonas Dehning, Sebastian B Mohr, Sebastian Contreras, et al.
Cell Reports|July 12, 2018
Myosin II Synergizes with F-Actin to Promote DNGR-1-Dependent Cross-Presentation of Dead Cell-Associated AntigensOliver Schulz, Pavel Hanč, Jan P Böttcher, et al.
European Journal of Haematology|August 23, 2006
Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatmentUlrike Heider, Martin Kaiser, Christian Müller, et al.
Nucleic Acids Research|June 15, 2006
Identifying an interaction site between MutH and the C-terminal domain of MutL by crosslinking, affinity purification, chemical coding and mass spectrometryRobert Ahrends, Jan Kosinski, Dieter Kirsch, et al.
Cell Cycle (Georgetown, Tex.)|February 26, 2015
Targeting multiple tyrosine kinase receptors with Dovitinib blocks invasion and the interaction between tumor cells and cancer-associated fibroblasts in breast cancerChuanbing Zang, Jan Eucker, Piet Habbel, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
American Journal of Clinical Pathology|November 13, 2004
Expression of matrix metalloproteinase (MMP)-1, MMP-2, MMP-9, cathepsin B, and urokinase plasminogen activator in non-skull base chordomaTakahiko Naka, Carsten Boltze, Doerthe Kuester, et al.
Blood|October 24, 2002
Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cellsJulio Aliberti, Oliver Schulz, Daniel J Pennington, et al.
Human Pathology|October 24, 2007
Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordomaTakahiko Naka, Doerthe Kuester, Carsten Boltze, et al.
Anticancer Research|September 10, 2014
TKI258, a multi-tyrosine kinase inhibitor is efficacious against human infant/childhood lymphoblastic leukemia in vitroJan Eucker, Chuanbing Zang, Yongan Zhou, et al.
Science (New York, N.Y.)|October 14, 2006
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphatesAndreas Pichlmair, Oliver Schulz, Choon Ping Tan, et al.
Nature Communications|January 18, 2023
Impact of the Euro 2020 championship on the spread of COVID-19Jonas Dehning, Sebastian B Mohr, Sebastian Contreras, et al.
Cell Reports|July 12, 2018
Myosin II Synergizes with F-Actin to Promote DNGR-1-Dependent Cross-Presentation of Dead Cell-Associated AntigensOliver Schulz, Pavel Hanč, Jan P Böttcher, et al.
European Journal of Haematology|August 23, 2006
Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatmentUlrike Heider, Martin Kaiser, Christian Müller, et al.
Nucleic Acids Research|June 15, 2006
Identifying an interaction site between MutH and the C-terminal domain of MutL by crosslinking, affinity purification, chemical coding and mass spectrometryRobert Ahrends, Jan Kosinski, Dieter Kirsch, et al.
Cell Cycle (Georgetown, Tex.)|February 26, 2015
Targeting multiple tyrosine kinase receptors with Dovitinib blocks invasion and the interaction between tumor cells and cancer-associated fibroblasts in breast cancerChuanbing Zang, Jan Eucker, Piet Habbel, et al.
Pageof 6